Vivoryon Therapeutics N.V.

ENXTAM:VVY Stock Report

Market Cap: €53.4m

Vivoryon Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

Vivoryon Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-1.5%

Buyback Yield

Total Shareholder Yield-1.5%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

May 28
Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

May 04
Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

Sep 02
Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Jan 26
Here's Why We're Not Too Worried About Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation

Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

Sep 16
Companies Like Vivoryon Therapeutics (AMS:VVY) Are In A Position To Invest In Growth

We Think Vivoryon Therapeutics (AMS:VVY) Can Afford To Drive Business Growth

May 10
We Think Vivoryon Therapeutics (AMS:VVY) Can Afford To Drive Business Growth

Is Vivoryon Therapeutics N.V.'s (AMS:VVY) Shareholder Ownership Skewed Towards Insiders?

Mar 11
Is Vivoryon Therapeutics N.V.'s (AMS:VVY) Shareholder Ownership Skewed Towards Insiders?

We're Hopeful That Vivoryon Therapeutics (AMS:VVY) Will Use Its Cash Wisely

Jan 14
We're Hopeful That Vivoryon Therapeutics (AMS:VVY) Will Use Its Cash Wisely

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if VVY's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VVY's dividend payments have been increasing.


Dividend Yield vs Market

Vivoryon Therapeutics Dividend Yield vs Market
How does VVY dividend yield compare to the market?
SegmentDividend Yield
Company (VVY)n/a
Market Bottom 25% (NL)2.5%
Market Top 25% (NL)6.2%
Industry Average (Biotechs)1.6%
Analyst forecast (VVY) (up to 3 years)0%

Notable Dividend: Unable to evaluate VVY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VVY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate VVY's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VVY has not reported any payouts.


Discover strong dividend paying companies